Infinity Pharmaceuticals

$2.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.19 (-6.55%) As of 7:45 PM UTC today

Why Robinhood?

You can buy or sell INFI and other stocks, options, and ETFs commission-free!

About INFI

Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA. The listed name for INFI is Infinity Pharmaceuticals, Inc. Common Stock.

CEO
Adelene Q. Perkins
Employees
25
Headquarters
Cambridge, Massachusetts
Founded
1995
Market Cap
257.51M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.03M
High Today
$3.06
Low Today
$2.47
Open Price
$2.99
Volume
3.93M
52 Week High
$5.98
52 Week Low
$0.60

INFI Earnings

-$0.20
-$0.11
-$0.01
$0.08
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, After Hours

You May Also Like

CLVT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure